Hikma Pharmaceutical Dividend yield

Hikma Pharmaceutical is part of Pharmaceuticals and Biotechnology business, which is part of Health Care industry. Hikma Pharmaceutical is a company from UK, and his stocks are publicly traded.

Hikma Pharmaceutical stock dividend

Hikma Pharmaceutical paid a total dividend of 111 million GBP last year, for a market value of 4,838 millions (Market Cap 3,530 millions). Hikma Pharmaceutical dividend per share is 0.50 GBP, and his stock market price 21.89 GBP.

According to the chart below, where dividend yield is displayed, Hikma Pharmaceutical has a dividend yield of 2.28%, which is lower than the amount offered by the market average , but bigger than Health Care industry. Dividend yields are similar among companies from the same industry, so it is a positive sign for the company.

In addition, you should compare Hikma Pharmaceutical stocks dividend with other Pharmaceuticals and Biotechnology companies or other of the highest UK dividend stocks list.

Hikma Pharmaceutical Dividend Payout

About the ability of Hikma Pharmaceutical to maintain his current dividend of GBP 0.50 per share, an amount that accounts for 2.28%, we should study its payout ratio both on earnings and on cash-flows (see chart below). Hikma Pharmaceutical payout on ernings is currently 47.17%, which is higher than the market average, and companies of Health Care industry, which are 39.34% and 23.54% respectively. Both figures show that Hikma Pharmaceutical can have problems to keep with his present dividend yield.

The payout on earnings should be complemented with the payout on cash flow since it is this last amount the one which can be distributed to shareholders. Cash flow per share of Hikma Pharmaceutical is GBP 1.71 per share, which is higher than the dividend per share paid by the company of GBP 0.50, so the company generates enough cash to maintain his dividend in the future.

The following figure shows payout ratios over earnings and cashflow of Hikma Pharmaceutical, compared againt world market average, UK companies, Health Care industry and Pharmaceuticals and Biotechnology sector companies.

Hikma Pharmaceutical Dividend History

Below you will find a table with the historical evolution of Hikma Pharmaceutical's dividend stock, both in percentage and in GBP, its Payout on Earnings and the number of shares (in case there is an split, number shares altered the dividend per share).

Year	Yield	GBP	Paypout	Shares*
Present	2.28%	0.50	47.17%	221
2022	2.79%	0.43	25.75%	220
2021	1.67%	0.37	22.84%	231
2020	1.49%	0.38	21.11%	230
2019	1.57%	0.31	31.00%	242
2018	1.49%	0.26	-9.85%	241
2017	2.31%	0.26	41.94%	240
2016	1.35%	0.23	30.67%	239
2015	0.80%	0.17	18.28%	198

*In millions

Then you can see the evolution of Hikma Pharmaceutical dividend stock, and compare it with the average of UK stocks and that of the Pharmaceuticals and Biotechnology stocks.

Hikma Pharmaceutical Stock performance

Finally, last moth Hikma Pharmaceutical showed a return of 4.80% compared to a worldwide -2.49% average, and a -2.07% of Health Care firms. Over the last year, the company obtained a 66.70% versus a worldwide performance of a 8.71%. More detailed information can be seen in the following graph for UK and Pharmaceuticals and Biotechnology firms.